In a study published in Psycho-Oncology, excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon ...
Sep 5, 2019
0
1
A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decadeslong quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, ...
Aug 26, 2019
0
326
An international survey of more than 4000 cancer patients and carers, including 850 Australians, has highlighted the need to tackle shortcomings in diagnosis, treatment and psychological support as well as high medical costs.
Aug 9, 2019
0
1
Elderly cancer patients who are HIV-positive, particularly those with prostate and breast cancers, have worse outcomes compared to cancer patients in the same age range who do not have HIV. A Moffitt Cancer Center researcher, ...
Aug 1, 2019
0
1
July 24, 2019—A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating ...
Jul 24, 2019
0
3
A new study by University of Kentucky Markey Cancer Center researchers shows a higher mortality rate for prostate cancer among men from Appalachian Kentucky compared to men from non-Appalachian Kentucky.
Jul 23, 2019
0
1
New research into a genetic mutation's role in breast cancer could open new treatment options for lung cancer, according to a Michigan State University scientist.
Jul 23, 2019
0
34
Alzheimer's disease may be a risk for older prostate cancer patients given hormone-blocking treatment, a large, U.S. government-funded analysis found.
Jul 5, 2019
1
74
Mortality due to prostate cancer is usually related to its likelihood to metastasize, especially to bone. Prognostic biomarkers are urgently needed to predict disease aggression so that appropriate treatment can be selected. ...
Jun 12, 2019
0
16
Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer ...
Jun 3, 2019
0
24
